158 related articles for article (PubMed ID: 34401966)
1. Digital Image Disintegration Analysis: a Novel Quality Control Method for Fast Disintegrating Tablets.
Malallah O; Rashid Z; Li CL; Alqurshi A; Alhanan MA; Forbes B; Royall PG
AAPS PharmSciTech; 2021 Aug; 22(7):219. PubMed ID: 34401966
[TBL] [Abstract][Full Text] [Related]
2. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
[TBL] [Abstract][Full Text] [Related]
3. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
[TBL] [Abstract][Full Text] [Related]
4. An in vitro analysis of disintegration times of different formulations of olanzapine orodispersible tablet: a preliminary report.
Hobbs D; Karagianis J; Treuer T; Raskin J
Drugs R D; 2013 Dec; 13(4):281-8. PubMed ID: 24170256
[TBL] [Abstract][Full Text] [Related]
5. Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: evaluation of wetting and disintegration of tablet on the basis of surface free energy.
Fukami J; Ozawa A; Yoshihashi Y; Yonemochi E; Terada K
Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1536-9. PubMed ID: 16327184
[TBL] [Abstract][Full Text] [Related]
6. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera.
Morita Y; Tsushima Y; Yasui M; Termoz R; Ajioka J; Takayama K
Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1181-6. PubMed ID: 12237533
[TBL] [Abstract][Full Text] [Related]
8. Disintegration propensity of tablets evaluated by means of disintegrating force kinetics.
Massimo G; Catellani PL; Santi P; Bettini R; Vaona G; Bonfanti A; Maggi L; Colombo P
Pharm Dev Technol; 2000; 5(2):163-9. PubMed ID: 10810746
[TBL] [Abstract][Full Text] [Related]
9. [Establishment of a Novel Method to Evaluate Water Permeation Rates by Combining the Dynamic Contact Angle and Thermographic Approach: Significance of Disintegration Properties of Orally Disintegrating Tablets].
Suzuki T; Kurano T; Kanazawa T; Suzuki N
Yakugaku Zasshi; 2020; 140(8):1071-1080. PubMed ID: 32741865
[TBL] [Abstract][Full Text] [Related]
10. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution.
Gupta A; Hunt RL; Shah RB; Sayeed VA; Khan MA
AAPS PharmSciTech; 2009; 10(2):495-9. PubMed ID: 19387843
[TBL] [Abstract][Full Text] [Related]
11. The preparation of rapidly disintegrating tablets in the mouth.
Sugimoto M; Matsubara K; Koida Y; Kobayashi M
Pharm Dev Technol; 2001 Nov; 6(4):487-93. PubMed ID: 11775950
[TBL] [Abstract][Full Text] [Related]
12. Formulation of Herbal Fast Disintegrating Tablets and its ex-vivo Study for Anti-histaminic Activity in Guinea Pig Ileum.
Puri D; Bhandari A; Gaur PK; Yasir M; Kumar SS; Choudhary D; Saxena PK
Curr Clin Pharmacol; 2018; 13(2):128-135. PubMed ID: 29521214
[TBL] [Abstract][Full Text] [Related]
13. Preparation and optimization of fast disintegrating tablets of isosorbide dinitrate using lyophilization method for oral drug delivery.
Alami-Milani M; Salatin S; Nasiri E; Jelvehgari M
Ther Deliv; 2021 Jul; 12(7):523-538. PubMed ID: 34098729
[No Abstract] [Full Text] [Related]
14. A novel method for predicting disintegration time in the mouth of rapidly disintegrating tablet by compaction analysis using TabAll.
Shibata Y; Yamamoto Y; Fujii M; Kondoh M; Watanabe Y
Chem Pharm Bull (Tokyo); 2004 Nov; 52(11):1394-5. PubMed ID: 15516774
[TBL] [Abstract][Full Text] [Related]
15. Characterising the disintegration properties of tablets in opaque media using texture analysis.
Scheuerle RL; Gerrard SE; Kendall RA; Tuleu C; Slater NK; Mahbubani KT
Int J Pharm; 2015; 486(1-2):136-43. PubMed ID: 25791759
[TBL] [Abstract][Full Text] [Related]
16. Fabrication and optimization of fast disintegrating tablets employing interpolymeric chitosan-alginate complex and chitin as novel superdisintegrants.
Goel H; Tiwary AK; Rana V
Acta Pol Pharm; 2011; 68(4):571-83. PubMed ID: 21796940
[TBL] [Abstract][Full Text] [Related]
17. Strategies and formulations of freeze-dried tablets for controlled drug delivery.
Tran PHL; Lee BJ; Tran TTD
Int J Pharm; 2021 Mar; 597():120373. PubMed ID: 33577912
[TBL] [Abstract][Full Text] [Related]
18. Effect of processing methods on xylitol-starch base co-processed adjuvant for orally disintegrating tablet application.
Bin LK; Helaluddin ABM; Islam Sarker MZ; Mandal UK; Gaurav A
Pak J Pharm Sci; 2020 Mar; 33(2):551-559. PubMed ID: 32276897
[TBL] [Abstract][Full Text] [Related]
19. Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract.
Azman SEN; Abd Razak FS; Kamal WHBW; Zheng GK; Ming LC; Uddin AH; Sarker ZI; Bin LK
Int J Pharm Compd; 2020; 24(6):509-514. PubMed ID: 33217741
[TBL] [Abstract][Full Text] [Related]
20. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
